Skip to content
10-Q

Quarterly Report

Lomond Therapeutics Holdings, Inc.

0001213900-24-042959

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 14, 2024 5M sh
Current Liabilities Q1 2024 · Mar 31, 2024 $128.9K
Current Liabilities Q1 2024 · Dec 31, 2023 $103.2K
Total Liabilities Q1 2024 · Mar 31, 2024 $128.9K
Total Liabilities Q1 2024 · Dec 31, 2023 $103.2K
Current Assets Q1 2024 · Mar 31, 2024 $15.39K
Current Assets Q1 2024 · Dec 31, 2023 $984
Total Assets Q1 2024 · Mar 31, 2024 $15.39K
Total Assets Q1 2024 · Dec 31, 2023 $984
Shares Diluted Q1 2024 · Mar 31, 2023 5M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$10.46K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$67.41K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$54.28K
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Sga Expense Q1 2024 · Mar 31, 2023 $13.13K
Net Income Q1 2024 · Mar 31, 2023 −$13.13K
Operating Income Q1 2024 · Mar 31, 2023 −$13.13K